By Karl Simpson (auth.), Bernardo Sorj, Mark Cantley, Karl Simpson (eds.)
The accession of Spain and Portugal to club of the ecu group in January 1985 not just introduced new energy to the eu initiative, yet served as a robust reminder of the wider dimensions of the Spanish- and Portuguese-speaking worlds. A reinforcement of Europe's common and historic interna tionalism of outlook used to be rather correct within the context of biotechnology; for the subtle multi-disciplinary medical base, and the different vast program parts, strength on biotechnol ogy an internationalism either for entry to medical strength, and for entry to all over the world markets. Such used to be the explanation for 'SOBELA': a 'Seminar on Biotechnol ogy in Europe and Latin America', which in April 1987 introduced a few 50 Latin American marketers, policy-makers and educational leaders to Europe and to Brussels. on the Commission's Borschette convention Centre, they heard displays from 11 of the neighborhood Member States, each one emphasising its strengths in bio know-how and its curiosity in selling business collaboration with corporations in Latin the US. The seminar used to be opened via speeches from Vice-President Karl Heinz Narjes on behalf of the fee, and via His Excellency Luis Ramiro Alfonsin of Argentina, senior Latin American diplomat in Brussels. within the ultimate consultation, Directors-General Paolo Fasella (Science, examine and improvement, DG XII) and Jean Durieux (External kinfolk, DG I) welcomed Their Excellencies the ambas sadors from Argentina, Mexico, Brazil, Uruguay and Colombia.
Read or Download Biotechnology in Europe and Latin America: Prospects for Co-operation PDF
Best biotechnology books
Normal foundation biopolymers are beautiful to be used in biomedical functions, in part because of their biocompatibility and degradation features. This publication comprehensively experiences this crucial topic in six in-depth sections. half 1 discusses the resources, homes, amendment and processing of natural-based polymers, while within the moment part floor facets are reviewed.
Many constructing nations are exploring even if biotechnology has a job in addressing nationwide concerns similar to nutrients safety and environmental remediation, and are contemplating even if the putative advantages of the expertise - for instance, permitting better agricultural productiveness and balance within the nutrients provide - outweigh matters that the know-how may perhaps pose a risk - to biodiversity, health and wellbeing, and native jobs.
In Biotechnology for Fuels and chemical substances: The Twenty-Third Symposium, top US and overseas researchers from academia, undefined, and executive current cutting-edge examine on how biotechnology is getting used to provide economically aggressive fuels and chemical substances. The articles diversity from a dialogue of advances in biomass construction and processing, to commercialization of bio-based items.
Immobilized Enzymes for business Reactors goals to lead the engineer and scientist alongside the trail towards the commercial software of immobilized enzymes. it is crucial to spot the risks and pitfalls that might be encountered, not just within the preliminary study efforts, but in addition in the course of the ultimate engineering levels of a advertisement application.
Extra info for Biotechnology in Europe and Latin America: Prospects for Co-operation
Several companies such as Biocon, Nochtec, are having success in exports. Italy Has come rather late into the arena, but is putting money into a major national initiative to support industry in a range of missionorientated projects. The government has talked of an Italian Human Genome project. Major companies are in acquisition moods and have got hold of biotech skills. Farmitalia, Ferruzzi and the ENI group (including Sclavo) are leading firms. Major academic industrial collaboration is being encouraged.
The Regional Authorities also allocate funds to university research in biotechnology. Some Prominent Research Groups in the Areas of Agriculture and Medicine Agriculture Professors Van Montagu and Schell from Rijksuniversiteit Gent are active in plant molecular genetics and Agrobacterium. Professor Briquet at the Universite Catholique de Louvain is renowned for his work on cytoplasmic male sterility. Professors Bernier, Universite de l'Etat a Liege, and Jacobs, Vrije Universiteit Brussel, work in the area of molecular physiology of plants.
France has major strengths in bioreactors centred on Daniel Thomas in the University of Compiegne. Agro biotechnology is another strong field, Limagrain has developed artificial seeds and Moet-Hennessy is looking at the micropropagation of woody plants. Club Agri has a 4 year, US$3 million programme of club sponsored research. Sanofi, an Elf Aquitaine subsidiary with major healthcare biotech commitments had turnover of more than US$600 million last year. Transgene, the rDNA and cell biology firm works in collaboration with several major French companies and is starting to be a candidate for entry into the international league.
Biotechnology in Europe and Latin America: Prospects for Co-operation by Karl Simpson (auth.), Bernardo Sorj, Mark Cantley, Karl Simpson (eds.)